Fierce Pharma
JANUARY 5, 2023
AstraZeneca, Sanofi tee up 3-way RSV battle in 2023 as FDA signals expedited review for antibody. aliu. Thu, 01/05/2023 - 10:13.
MedCity News
JANUARY 5, 2023
Providers are, in many cases, getting the equivalent of a Russian nesting doll of third-party risks whenever they acquire a complex new technology solution. Cybersecurity supply chain risk management is the process of identifying and mitigating potential risks that may arise from these third-party products and services within an organization’s IT infrastructure.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JANUARY 5, 2023
After large asset swap, Sanofi and Boehringer expect answers in Zantac dispute this year. esagonowsky. Thu, 01/05/2023 - 09:14.
MedCity News
JANUARY 5, 2023
Fewer new drugs won FDA approvals in 2022 compared to previous years, but some of the products that passed regulatory muster are indicative of trends expected to continue into 2023. For example, more gene and cell therapies are on track to face regulatory decisions in the coming year.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Fierce Pharma
JANUARY 5, 2023
Unleashing the power of R&D talent. jpiatt. Thu, 01/05/2023 - 12:07.
MedCity News
JANUARY 5, 2023
Through the partnership, food and meals will be offered as a service on HealthAlign’s marketplace. Season Health will provide those services to about 5,500 members a month of three out of the six largest Medicare Advantage plans.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JANUARY 5, 2023
Electronic Clinical Outcomes Assessment and digital health tools were well-suited to accommodate the rapid rise of virtual and telehealth shifts during the Covid-19 pandemic and there is no going back. The adoption of eCOA technology in mental healthcare research can make pivotal advancements in mental health patient care.
Fierce Pharma
JANUARY 5, 2023
Jazz sues generics makers for infringement on cannabis-derived epilepsy drug. zbecker. Thu, 01/05/2023 - 11:03.
MedCity News
JANUARY 5, 2023
There’s a lingering misperception among many patients, loved ones, and even healthcare professionals that hospice care is useful only in a patient’s last days or weeks of life.
Fierce Pharma
JANUARY 5, 2023
Pharma execs see inflation as the No. 1 challenge in 2023: survey. kdunleavy. Thu, 01/05/2023 - 10:10.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
JANUARY 5, 2023
Novocure’s electrical field-producing medical device, in combination with standard drug therapies, improved overall survival in a pivotal study that enrolled patients with advanced non-small cell lung cancer. The medtech company now plans to seek regulatory approvals.
Medgadget
JANUARY 5, 2023
Researchers at the University of Florida have created a point-of-care biosensor that can rapidly detect a biomarker for oral cancer. The device uses test strips, such as those used in blood glucose tests, to spot cell proliferation regulating inhibitor of protein phosphatase 2A (CIP2A), a protein biomarker that can reveal the presence of oral cancer.
MedCity News
JANUARY 5, 2023
Boston-based medical device company AVS recently raised $20 million in Series B funding to bring its arterial disease treatment closer to FDA clearance. The system that AVS is developing uses pressure waves to shatter calcium that has built up in arteries.
Clear Pivot
JANUARY 5, 2023
Warmth, hospitality, and friendliness are all crucial for senior living communities. In fact, your success as a business depends on it. These qualities are all easy to communicate with face-to-face interactions, so make sure you're taking advantage of one of the most effective ways to get them: events.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
MedCity News
JANUARY 5, 2023
The donation will go to the One Albuquerque Fund for its project called “The Gateway.” This project will create a new medical center that will provide emergency overnight beds and other services for those experiencing homelessness.
Pharmaceutical Technology
JANUARY 5, 2023
Capsida Biotherapeutics and Eli Lilly and Company ’s wholly owned subsidiary Prevail Therapeutics have announced a partnership for the development of non-invasive gene therapies for central nervous system (CNS) diseases. Under the multi-year strategic partnership, Prevail will detect and advance capsids, which are clinically translatable, along with its cargo to develop the transformative genetic medicines by using Capsida’s novel adeno-associated virus (AAV) engineering platform.
MedCity News
JANUARY 5, 2023
By creating a marketplace that empowers consumers to choose the right health care coverage for their unique and individual needs, CMS will continue to put consumers first and strengthen Medicare Advantage, already the chosen program of America’s seniors.
PharmExec
JANUARY 5, 2023
Using market access data from day one of your drug development and commercialization journey puts your brand in the best position to succeed at launch.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharma Pathway
JANUARY 5, 2023
Dr. Reddy’s Laboratories Ltd.-Walk-In Drive for Multiple Positions On 8th Jan’ 2023. Job Description. Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products.
Teachntest
JANUARY 5, 2023
Definition: A prescription is a written order for a patient to receive a medication or treatment. It is typically written by a physician or other authorized healthcare provider and given to the patient, who then takes it to a pharmacy to have it filled.
Copyright Clearance Center
JANUARY 5, 2023
The post GitHub is Sued, and We May Learn Something About Creative Commons Licensing appeared first on Copyright Clearance Center.
Pharma Pathway
JANUARY 5, 2023
Aurobindo Pharma-Walk-In Interviews for Quality Control/ Production On 7th Jan’ 2023. Job Description. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
PharmaTech
JANUARY 5, 2023
The agency revised a regulation to enable pharmacies to dispense mifepristone directly to individuals with a prescription.
PharmaVoice
JANUARY 5, 2023
As controversies abound and new drugs rise on the regulatory horizon, this year will be big for Alzheimer’s.
pharmaphorum
JANUARY 5, 2023
Biotech Moderna, Inc. and OriCiro Genomics K.K. have announced they have entered into a definitive agreement for Moderna to acquire OriCiro at a cost of $85 million. The deal marks 10-year-old Moderna’s first acquisition. The company develops mRNA therapeutics and vaccines , and the move will enable it to utilise the synthetic biology and enzyme tech of 2018-founded Japanese company OriCiro, which develops cell-free DNA synthesis and amplification technologies, and thereby expand Moderna’s portf
Pharma Pathway
JANUARY 5, 2023
SMS Lifesciences India Limited- Walk-In Interviews for Production/ Production Documentation/ Maintenance On 7th Jan’ 2023. Job Description. Walk-In Interviews for Freshers & Experienced in Production/ Production Documentation/ Maintenance @ SMS Lifesciences India Limited. Departments: Production/ Production Documentation/ Maintenance. Position: Trainee Chemit/ Sr.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
PharmaVoice
JANUARY 5, 2023
Why Evernow CEO Alicia Jackson thinks menopause is the perfect inroad to helping women live longer lives.
Copyright Clearance Center
JANUARY 5, 2023
The post The Boston Globe Again Names CCC a Top Place to Work appeared first on Copyright Clearance Center.
PharmaTimes
JANUARY 5, 2023
Agreement covers cell-based studies, with an additional option to further develop screening activities
PharmExec
JANUARY 5, 2023
In episode 125, Chris Fox, president of Novartis Gene Therapies, shares insights into her work with gene therapies, commercialization challenges, her role at Novartis, and what the team are most excited about in 2023.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
233 
Let's personalize your content